For decades, treatment of peripheral artery disease has focused almost exclusively on restoring blood flow. Now, new research ...
BACKGROUND: Peripheral artery disease (PAD) and its severe form, chronic limb-threatening ischemia (CLTI), significantly impair blood flow to the lower extremities, affecting millions of adults ...
Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...
Cutting off blood flow can prematurely age the bone marrow, weakening the immune system’s ability to fight cancer, according to a new study from NYU Langone Health. The team’s preclinical study showed ...
For patients with chronic, limb-threatening ischemia due to atherosclerosis that affects the arteries below the knee, a revascularization strategy using endovascular treatment as the first option was ...
Adjust the colors to reduce glare and give your eyes a break. Use one of the services below to sign in to PBS: You've just tried to add this video to My List. But first, we need you to sign in to PBS ...
Peripheral artery disease affects approximately 236 million persons worldwide and is diagnosed with an ankle–brachial index of less than 0.90. Among older persons, 3.3% of those without peripheral ...
Critical limb ischemia (CLI) is a severe complication of peripheral artery disease (PAD). PAD occurs when plaque builds up in blood vessels that deliver blood from the heart to other areas. CLI ...
The FDA approved the Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ischemia (CLTI) below the knee, Abbott announced on Monday. This system represents the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results